Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 76

1.

Early pharmacokinetics and clinical effects of oral D-amphetamine in normal subjects.

Angrist B, Corwin J, Bartlik B, Cooper T.

Biol Psychiatry. 1987 Nov;22(11):1357-68.

PMID:
3663788
2.

Acute tolerance to subjective but not cardiovascular effects of d-amphetamine in normal, healthy men.

Brauer LH, Ambre J, De Wit H.

J Clin Psychopharmacol. 1996 Feb;16(1):72-6.

PMID:
8834422
3.

Biological and behavioral responses to D-amphetamine, alone and in combination with the serotonin3 receptor antagonist ondansetron, in healthy volunteers.

Grady TA, Broocks A, Canter SK, Pigott TA, Dubbert B, Hill JL, Murphy DL.

Psychiatry Res. 1996 Aug 30;64(1):1-10.

PMID:
8888359
4.

Effects of setting on the subjective and behavioral effects of d-amphetamine in humans.

Zacny JP, Bodker BK, de Wit H.

Addict Behav. 1992;17(1):27-33.

PMID:
1595423
5.
6.

Behavioral and subjective effects of d-amphetamine and modafinil in healthy adults.

Makris AP, Rush CR, Frederich RC, Taylor AC, Kelly TH.

Exp Clin Psychopharmacol. 2007 Apr;15(2):123-33.

PMID:
17469936
7.

Subjective and behavioral effects of repeated d-amphetamine in humans.

Wachtel SR, de Wit H.

Behav Pharmacol. 1999 May;10(3):271-81.

PMID:
10780242
8.

Effects of food deprivation on subjective responses to d-amphetamine in humans.

Zacny JP, de Wit H.

Pharmacol Biochem Behav. 1989 Dec;34(4):791-5.

PMID:
2623032
9.

Enhanced response to repeated d-amphetamine challenge: evidence for behavioral sensitization in humans.

Strakowski SM, Sax KW, Setters MJ, Keck PE Jr.

Biol Psychiatry. 1996 Nov 1;40(9):872-80.

PMID:
8896773
10.

Reinforcing and subject-rated effects of methylphenidate and d-amphetamine in non-drug-abusing humans.

Rush CR, Essman WD, Simpson CA, Baker RW.

J Clin Psychopharmacol. 2001 Jun;21(3):273-86.

PMID:
11386490
11.

Alprazolam attenuates the behavioral effects of d-amphetamine in humans.

Rush CR, Stoops WW, Wagner FP, Hays LR, Glaser PE.

J Clin Psychopharmacol. 2004 Aug;24(4):410-20.

PMID:
15232333
12.

Acute hydrocortisone administration does not affect subjective responses to d-amphetamine in humans.

Wachtel SR, Charnot A, de Wit H.

Psychopharmacology (Berl). 2001 Jan;153(3):380-8.

PMID:
11271411
13.

The prediction of individual differences in response to D-amphetamine in healthy adults.

Alessi SM, Greenwald M, Johanson CE.

Behav Pharmacol. 2003 Feb;14(1):19-32.

PMID:
12576878
14.

Individual differences in responses to ethanol and d-amphetamine: a within-subject study.

Holdstock L, de Wit H.

Alcohol Clin Exp Res. 2001 Apr;25(4):540-8.

PMID:
11329494
15.

Alcohol choice and amphetamine effects in light and moderate drinkers.

Stoops WW, Fillmore MT, Poonacha MS, Kingery JE, Rush CR.

Alcohol Clin Exp Res. 2003 May;27(5):804-11.

PMID:
12766625
16.

Cardiovascular effects of 0.5 milligrams per kilogram oral d-amphetamine and possible attenuation by haloperidol.

Angrist B, Sanfilipo M, Wolkin A.

Clin Neuropharmacol. 2001 May-Jun;24(3):139-44.

PMID:
11391124
17.

Amphetamines, growth hormone and narcolepsy.

Parkes JD, Debono AG, Jenner P, Walters J.

Br J Clin Pharmacol. 1977 Jun;4(3):343-9.

18.

Oral D-fenfluramine and neuroendocrine challenge: problems with the 30 mg dose in men.

Goodwin GM, Murray CL, Bancroft J.

J Affect Disord. 1994 Feb;30(2):117-22.

PMID:
8201126
19.
20.

High dose pimozide does not block amphetamine-induced euphoria in normal volunteers.

Brauer LH, De Wit H.

Pharmacol Biochem Behav. 1997 Feb;56(2):265-72.

PMID:
9050084

Supplemental Content

Support Center